Metacel Pharmaceuticals LLC
General
Total Cases3
Active Cases2
Patents1
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/21/25 | CLERK'S QUALITY CONTROL MESSAGE - The [2] Corporate Disclosure Statement submitted by William Hare on 2/20/2025 contains an improper signature. Only the filing user is permitted to sign electronically filed documents with an s/. PLEASE RESUBMIT THE DOCUMENT WITH A PROPER ELECTRONIC SIGNATURE. This submission will remain on the docket unless otherwise ordered by the court. (jjc) (Entered: 02/21/2025) | |
| 02/20/25 | Corporate Disclosure Statement by METACEL PHARMACEUTICALS LLC identifying Rosemont Pharmaceuticals, Inc. as Corporate Parent.. (HARE, WILLIAM) (Entered: 02/20/2025) | |
| 02/20/25 | COMPLAINT against METACEL PHARMACEUTICALS LLC ( Filing and Admin fee $ 405 receipt number ANJDC-16034190) , Related Case Selected, filed by METACEL PHARMACEUTICALS LLC. (Attachments: # [1] Exhibit, # [2] Civil Cover Sheet)(HARE, WILLIAM) (Entered: 02/20/2025) | |
| 08/08/23 | First Amended ANSWER to Complaint, Affirmative Defenses and, COUNTERCLAIM against METACEL PHARMACEUTICALS LLC by RUBICON RESEARCH PRIVATE LIMITED.(MYER, R) (Entered: 08/08/2023) | |
| 08/08/23 | Pursuant to 152 Order, Status Conference set for 8/11/2023 at 10:00 AM before Magistrate Judge Jose R. Almonte. (dam) (Entered: 08/08/2023) | |
| 08/08/23 | ORDER granting 130 Defendant's Motion for Leave to File a Counterclaim; directing Defendant to file its Amended Answer asserting the proposed counterclaim by 8/14/2023. Upon the filing of the Amended Answer, Defendants antitrust counterclaim for sham litigation shall be STAYED until a decision is issued on Plaintiff's pending motion for reconsideration (ECF No. 146 ) and until the entry of final judgment as to Metacels patent infringement claim. A Status Conference is scheduled for 8/11/2023 at 10:00 AM. Signed by Magistrate Judge Jose R. Almonte on 8/7/2023. (dam) (Entered: 08/08/2023) | |
| 08/07/23 | Joint MOTION to Seal Document 147 Brief in Support of Motion,, by METACEL PHARMACEUTICALS LLC. (Attachments: # 1 Declaration of Matthew D. Zapadka, Esq., # 2 Exhibit 1 - Index in support of Joint Motion to Seal, # 3 Declaration of Timothy H. Kratz, Esq., # 4 Exhibit 1 - Index in support of Joint Motion to Seal, # 5 Text of Proposed Order)(CALMANN, ARNOLD) (Entered: 08/07/2023) | |
| 08/07/23 | REDACTION to 147 Brief in Support of Motion,, by METACEL PHARMACEUTICALS LLC. (Attachments: # 1 UNREDACTED Declaration of Matthew D. Zapadka, Esq., # 2 REDACTED Exhibit 1 to the Declaration of Matthew D. Zapadka, Esq., # 3 REDACTED Exhibit 2, # 4 REDACTED Declaration of David R. Savello, Ph.D., # 5 REDACTED Exhibit 1 to Declaration of David R. Savello, Ph.D., # 6 REDACTED Exhibit 2, # 7 REDACTED Exhibit 3, # 8 UNREDACTED Exhibit 4, # 9 UNREDACTED Exhibit 5)(CALMANN, ARNOLD) (Entered: 08/07/2023) | |
| 08/07/23 | Minute Entry: On 8/7/2023 the court entered a decision on the motion at ECF 130. An Order was read into the record by Magistrate Judge Jose R. Almonte. A status conference is scheduled for August 11, 2023, at 10:00 a.m. For the conference, please dial (888) 684-8852 and enter access code 1364268. (Court Reporter, ECR) (akw) (Entered: 08/07/2023) | |
| 08/07/23 | Set Deadlines as to 151 Joint MOTION to Seal 147 Brief in Support of Motion. Motion set for 9/5/2023 before Magistrate Judge Jose R. Almonte. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk's Office and does not supersede any previous or subsequent orders from the Court. (dam) (Entered: 08/07/2023) |